Development and validation of a liquid chromatography/tandem mass spectrometry method for the determination of DMXAA in human and mouse plasma
スポンサーリンク
概要
- 論文の詳細を見る
- 2007-06-01
著者
-
ZHAO Ming
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
-
HE Ping
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
-
He Ping
The Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University School Of Medicine
-
ZHANG Xiaosong
The Ludwig Center for Cancer Genetics & Therapeutics, Johns Hopkins University School of Medicine
-
RUDEX Michelle
The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
-
VOGELSTEIN Bert
The Ludwig Center for Cancer Genetics & Therapeutics, Johns Hopkins University School of Medicine
-
Rudex Michelle
The Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University School Of Medicine
-
Zhang Xiaosong
The Ludwig Center For Cancer Genetics & Therapeutics Johns Hopkins University School Of Medicine
-
Zhao Ming
The Sidney Kimmel Comprehensive Cancer Center Johns Hopkins University School Of Medicine
-
Vogelstein Bert
The Ludwig Center For Cancer Genetics & Therapeutics Johns Hopkins University School Of Medicine
関連論文
- Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate ON 01910. Na, a mitotic progression modulator, in human plasma
- Specific method for determination of gefitinib in human plasma, mouse plasma and tissues using high performance liquid chromatography coupled to tandem mass spectrometry
- Low-Complexity ICI Cancellation in Frequency Domain for OFDM Systems in Time-Varying Multipath Channels (Wireless Communication Technologies)
- A rapid and sensitive method for determination of sorafenib in human plasma using a liquid chromatography/tandem mass spectrometry assay
- Development and validation of a liquid chromatography/tandem mass spectrometry method for the determination of DMXAA in human and mouse plasma
- Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate dimethyl benzoylphenylurea (BPU) and its five metabolites in human plasma and urine for clinical pharmacology studies
- Quantitation of sorafenib and its active metabolite sorafenib N-oxide in human plasma by liquid chromatography-tandem mass spectrometry
- Determination of salirasib (S-trans,trans-farnesylthiosalicylic acid) in human plasma using liquid chromatography-tandem mass spectrometry
- Quantification of sunitinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry